Schrodinger (NASDAQ:SDGR) Sets New 1-Year High – Here’s What Happened

Schrodinger, Inc. (NASDAQ:SDGR) reached a new 52-week high during trading on Wednesday. The stock traded as high as $32.11 and last traded at $32.0760, with a volume of 1196601 shares. The stock had previously closed at $30.33.

Wall Street Analyst Weigh In

SDGR has been the subject of several recent analyst reports. Wall Street Zen upgraded shares of Schrodinger from a “strong sell” rating to a “hold” rating in a research report on Saturday, August 8th. Weiss Ratings upgraded shares of Schrodinger from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, August 27th. Finally, UBS Group assumed coverage on shares of Schrodinger in a research note on Friday, August 14th. They issued a “neutral” rating and a $19.00 price target for the company. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $20.80.

Schrodinger Stock Performance

The firm has a market cap of $2.35 billion, a price-to-earnings ratio of -43.05 and a beta of 1.69. The company has a 50 day moving average price of $20.48 and a 200 day moving average price of $16.04.

Schrodinger (NASDAQ:SDGR) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.49. The firm had revenue of $58.89 million during the quarter, compared to the consensus estimate of $47.19 million. Schrodinger had a negative return on equity of 16.37% and a negative net margin of 20.98%.The company’s quarterly revenue was up 7.5% on a year-over-year basis. During the same period last year, the company earned ($0.65) EPS. On average, research analysts forecast that Schrodinger, Inc. will post -1.5 earnings per share for the current year.

Insider Buying and Selling at Schrodinger

In related news, insider Karen Akinsanya sold 31,599 shares of Schrodinger stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $29.37, for a total value of $928,062.63. Following the completion of the sale, the insider owned 69,956 shares in the company, valued at approximately $2,054,607.72. This trade represents a 31.12% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 10.10% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the company. Kestra Advisory Services LLC boosted its position in shares of Schrodinger by 2.0% during the first quarter. Kestra Advisory Services LLC now owns 51,429 shares of the company’s stock worth $584,000 after buying an additional 1,002 shares during the period. EverSource Wealth Advisors LLC raised its holdings in shares of Schrodinger by 722.8% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,374 shares of the company’s stock valued at $25,000 after buying an additional 1,207 shares during the period. Hantz Financial Services Inc. lifted its stake in Schrodinger by 5,025.8% during the 4th quarter. Hantz Financial Services Inc. now owns 1,589 shares of the company’s stock worth $28,000 after acquiring an additional 1,558 shares in the last quarter. Entropy Technologies LP lifted its stake in Schrodinger by 17.9% during the 1st quarter. Entropy Technologies LP now owns 15,257 shares of the company’s stock worth $173,000 after acquiring an additional 2,311 shares in the last quarter. Finally, Purpose Unlimited Inc. purchased a new position in Schrodinger during the 4th quarter valued at about $47,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

About Schrodinger

Schrödinger, Inc develops computational software designed to accelerate drug discovery and materials science research. Its platform uses physics-based modeling, machine learning and related computational methods to help scientists analyze molecular structures, predict interactions and identify potential compounds for further development.

The company’s software products support a range of research activities, including molecular modeling, virtual screening, structure-based drug design, free-energy calculations and collaborative data management.